As reported by Reuters, U.S. pharmaceutical giant Eli Lilly has launched its Mounjaro KwikPen in India, expanding its portfolio of treatments for diabetes and obesity.
Lupin Limited, a leading global pharmaceutical company, has announced the launch of its Prucalopride Tablets in 1 mg and 2 mg strengths in the United States, following the recent approval of its Abbreviated New Drug Application (ANDA) by the U.S. Food and Drug Administration (FDA).
In a promising development for transplant medicine, global healthcare leader Sanofi has announced that its investigational therapy riliprubart has received Orphan Drug Designation from the U.S. Food and Drug Administration.
A pioneering gene therapy engineered by researchers at the University of California San Diego (UCSD) School of Medicine demonstrates remarkable promise in halting, and potentially reversing, cognitive decline in preclinical Alzheimer’s models.
Glenmark Pharmaceuticals Ltd., a research-driven global pharmaceutical company, has announced the launch of TEVIMBRA® (tislelizumab) in India, marking its official entry into the immuno-oncology segment.
Chronic pain is a debilitating condition that severely impacts quality of life, often leading to reliance on opioid medications with their severe side effects and addiction risks.
Demonstrable experience in Neuroscience or RNA Biochemistry in the form of publication. Experience in animal handling, viral injections in brain and animal behaviour or sequencing data analysis.
The Alexander von Humboldt Foundation presents one Carl Zeiss Humboldt Research Award funded by the Carl-Zeiss-Stiftung per year to an internationally renowned academic from abroad in recognition of the award winner’s entire previous academic record as well as their extraordinary potential.
Post Graduate Degree in Life Sciences Biotechnology, Biochemistry, Microbiology, Immunology, etc. with 2 years duration and NET, GATE qualification along with 2 years of research experience after Post-graduation in any of the following relevant field.
Candidates must possess a Masters degree in Life Sciences, Biochemistry, Biotechnology, Zoology, Bioinformatics, or allied areas with at least 55% marks from a recognized university. Additionally, candidates should have qualified NET, GATE to be eligible for this position.
Candidate should have a PhD degree in any field of Biological Sciences or Chemical Sciences with at least 1 research publication in a standard refereed journal as listed in Journal Citation Reports.
Exposure of analysis for Finished Products, Stability Samples and Raw Materials. Having Knowledge of Analytical Method Validation, Verification and Method Transfer. Having skill for data interpretation, troubleshooting. Pharma knowledge of Solid orals and Quality process.